Cirrhosis is a chronic and irreversible condition in which liver cells are progressively destroyed. As the cells undergo necrosis, the liver attempts to regenerate itself. The necrotic cells are replaced by new ones, but also by extensive connective tissue. Liver structure is altered so much that the flow of lymph and blood through this organ is much less efficient; the liver eventually stops functioning.
Cirrhosis affects twice as many males as females.
The primary treatment is to remove the underlying cause. This can involve eating a well balanced diet and abstinence from ethyl alcohol. Rest, frequent and small meals, and avoiding infection aid recovery.
There are many causes of cirrhosis but the most common is alcoholism. Other causes are:
Sudden and massive infection
Inborn errors in physical or chemical processes
Obstruction of liver bile ducts which may be due to stones, inborn errors, and tumors
Medications such as anticancer drugs and anesthetics
Heart disorders which obstruct the flow of blood
Signs & Symptoms
There are many signs and symptoms of cirrhosis, some of which are:
Weakness Malaise Anorexia Weight loss Loss of sexual interest Abdominal ache Nausea Diarrhea Constipation Indigestion
Fever Inflamed tongue Breathing difficulties Bleeding in esophagus or stomach Vomiting Vomiting of blood Hemorrhage of bleeding tendencies Enlarged and firm liver Enlarged spleen Jaundice Diminishing testes Loss of pubic and chest hairs Irregularities of menstruation Gynecomastia Musty breath Muscle atrophy Zinc deficiency Vitamin K deficiency Obtundation Coma Peripheral neuritis Asterixis Enlarged superficial abdominal veins "Spider veins" on skin of the upper body Tingling sensation in the skin of the hands and feet Redness of the mound of the palm at the base of the thumb
Structure & Function:
Adult Child/Adolescent Choline 100 - 500 mg n/a EPO* Inositol 100 - 500 mg n/a Lecithin* Manganese 5 - 10 mg n/a Quercetin* Rutin* Selenium 50 - 300 mcg n/a Vitamin B-6 25 - 100 mg n/a Vitamin B-9 400 - 800 mcg n/a Vitamin B-12 100 - 500 mcg n/a Vitamin C 1,000 - 3,000 mg n/a
* Please refer to the respective topic for specific nutrient amounts.
Lecithin (or its derivatives, like phosphatidylserine) are helpful, especially if the condition derives from alcohol abuse.
Antioxidant usage is heavily promoted, ranging from bioflavonoids like Quercetin and Rutin to superior antioxidants like Proanthocyanidins (Pycnogenol™).
One leading product, from the plant kingdom, is milk thistle (Silymarin).
Note: All amounts are in addition to those supplements having a Recommended Dietary Allowance (RDA). Due to individual needs, one must always be aware of a possible undetermined effect when taking nutritional supplements. If any disturbances from the use of a particular supplement should occur, stop its use immediately and seek the care of a qualified health care professional.
Cirrhosis with encephalopathy must be managed with a Low Protein Diet. The encephalopathy indicates that the sick liver is unable to clear toxic amines from the system. Additional dietary protein would cause further liberation of these amines.
Advanced cases of cirrhosis with encephalopathy require that proteins be completely withheld from the diet.
1.*Mercurius Vivus 30C
2. Hydrastis canadensis 30C
3. Hepar sulphuris calcareum 30C
4.*Mercurius dulcis 15C
Doses cited are to be administered on a 3X daily schedule, unless otherwise indicated. Dose usually continued for 2 weeks. Liquid preparations usually use 8-10 drops per dose. Solid preps are usually 3 pellets per dose. Children use 1/2 dose.
X = 1 to 10 dilution - weak (triturition)
C = 1 to 100 dilution - weak (potency)
M = 1 to 1 million dilution (very strong)
X or C underlined means it is most useful potency
Asterisk (*) = Primary remedy. Means most necessary remedy. There may be more than one remedy - if so, use all of them.
Boericke, D.E., 1988. Homeopathic Materia Medica.
Coulter, C.R., 1986. Portraits of Homeopathic Medicines.
Kent, J.T., 1989. Repertory of the Homeopathic Materia Medica.
Koehler, G., 1989. Handbook of Homeopathy.
Shingale, J.N., 1992. Bedside Prescriber.
Smith, Trevor, 1989. Homeopathic Medicine.
Ullman, Dana, 1991. The One Minute (or so) Healer.
Dandelion Root (Taraxacum officinale)
Milk thistle (silymarin)
Note: The misdirected use of an herb can produce severely adverse effects, especially in combination with prescription drugs. This Herbal information is for educational purposes and is not intended as a replacement for medical advice.
Dandelion Root is considered to be a specific antioxidant for the liver.
Ginseng is reputed to heal internal scarring.
Gotu kola has proven effective against alcohol-induced and idopathic cirrhosis but not chronic hepatitis. (Darnis, 1979)
Currently, a single herb, milk thistle (silymarin) is being used [70 - 210 mg t.i.d.], although it may form part of a combined therapy, including castor oil poultices and homeopathy. Silymarin can improve immune function in patients with cirrhosis. (Deak, 1990)
The German Commisssion E recommends Milk thistle fruit, exclusively, for cirrhosis of the liver.
Blumenthal, M (Ed.): The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council. Austin, TX. 1998.
Darnis, F et al., Use of a titrated extract of Centella asiatica in chronic hepatic disorders. Semin. Hosp. Paris, 1979, 55:1,749-1,750.
Deak, G et al., Immunomodulator effect of silymarin therapy in chronic alcoholic liver disease. Orv. Hetil. 1990, 131:1,291-1,292, 1,295-1,296.
Ferenci, P. et al., Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J. Hepat. 1989, 9:105.
Aromatherapy - Essential Oils
Garlic Essence, Ginger Essence.
Related Health Conditions
Alcoholism Anorexia Bleeding Cancer Coma Constipation Diarrhea Heart disorders Hemorrhage Hepatitis Icterus Indigestion Infection Malnutrition Menstruation Paranoia Syphilis Tumors Vomiting
Bland, Jeffrey. Medical Applications of Clinical Nutrition. New Canaan, Conn.: Keats, 1983.
Bories-P.N. & Campillo-B.: One-month regular oral nutrition in alcoholic cirrhotic patients. Changes of nutritional status, hepatic function and serum lipid pattern. Br-J-Nutr. 1994 Dec; 72(6): 937-46.
Cabr? E & Gassull MA: Nutritional support in liver disease. Eur J Gastroenterol Hepatol, 1995 Jun, 7:6, 528-32.
Cabr? E & Gassull MA: Polyunsaturated fatty acid deficiency in liver diseases: pathophysiological and clinical significance. Nutrition, 1996 Jul-Aug, 12:7-8, 542-8.
Caregaro L et al., Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr, 1996 Apr, 63:4, 602-9.
Caregaro L et al., Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis [see comments]. Nutrition, 1997 Mar, 13:3, 185-90.
Chandra S & Mehendale HM: Nutritional modulation of the final outcome of hepatotoxic injury by energy substrates: an hypothesis for the mechanism. Med Hypotheses, 1996 Mar, 46:3, 261-8.
Chasroff, I.J. & J.W. Ellis. 1983. Family Medical Guide, William Morrow and Company Inc., Pub. 594 pp.
Chicago Dietetic Assoc & the South Suburban Dietetic Assoc of Cook & Will Counties. 1981. Manual of Clinical Dietetics. Saunders Co., Philadephia.
Conn, H.O. 1983. Nutritional management of advanced liver disease. In Nutritional Support of the Seriously Ill Patient. R.W. Winters and H.L. Greene, eds. Academic Press, New York.
Corrao G et al., Exploring the role of diet in modifying the effect of known disease determinants: application to risk factors of liver cirrhosis. Am J Epidemiol, 1995 Dec 1, 142:11, 1136-46.
de la Maza MP et al., Effects of long-term vitamin E supplementation in alcoholic cirrhotics. J Am Coll Nutr, 1995 Apr, 14:2, 192-6.
de-la-Rubia-MA et al: [The assessment of the nutritional status of patients in the terminal stage of liver disease who are candidates for orthotopic liver transplantation]. Nutr-Hosp. 1994 May-Jun; 9(3): 163-9.
Eagles, J.A. & M.N. Randall. 1980. Handbook of Normal and Therapeutic Nutrition. Raven Press, New York. 323 pp.
Feinman, L. & Lieber, C.S. Nutrition and Liver Disease, Hospital Medicine, April 1990;150-166.
Frezza, M. et al: Oral S-Adenosylmethionine in The Symptomatic Treatment of Intrahepatic Cholestasis: A Double-Blind Placebo Controlled Study. Gastroenterology, 1990;99:211-215.
Goldbaum, J.S. Vitamin C in the Use of Megascorbate Therapy in General Medicine. Austalas Nurses Journal, 11 1982.
Guler-AH et al: Effect of copper on liver and bone metabolism in malnutrition. Turk-J-Pediatr. 1994 Jul-Sep; 36(3): 205-13.
Hamilton, H.K. ed. 1982. Professional Guide To Diseases Intermed Communications Inc. Pub, Springfield, Massachusetts. 1323 pp.
Hegsted, M.D. 1976. Present Knowlege In Nutrition. 4th ed. The Nutrition Foundation Pub., Washington D.C. 605 pp.
Heinerman, John, Ph.D.. 1982. Herbal Dynamics. Root of Life, Inc.: Publ.
Hikino, H. Antihepatotoxic constituents of Chinese drugs. Chin Pharm Bull 20 (1985): 415-417.
Hirsch S et al., Protein turnover in abstinent and non-abstinent patients with alcoholic cirrhosis [see comments]. J Am Coll Nutr, 1995 Feb, 14:1, 99-104.
Kalman DR & Saltzman JR: Nutrition status predicts survival in cirrhosis. Nutr Rev, 1996 Jul, 54:7, 217-9.
Kirschmann, J.D. 1990. Nutrition Almanac: Nutrition Search. McGrew-Hill: New York.
Lieber, C.S. Alcohol and the Liver. Hepatology, 4 (1984).
Linder, M.C. Other Trace Elements and the Liver. Semin. Liver Disease, 4 1984.
Loguercio C et al., Nutritional status and survival of patients with liver cirrhosis: anthropometric evaluation. Minerva Gastroenterol Dietol, 1996 Jun, 42:2, 57-60.
Mezey, E. 1982. Liver disease and protein needs. Ann Rvws Of Nutri, 2.
Muller-MJ et al: Metabolism of energy-yielding substrates in patients with liver cirrhosis. Clin-Investig. 1994 Aug; 72(8): 568-79.
Nompleggi, D.J. & Bonkovsky, H.L.: Nutritional supplementation on chronic liver disease: an analytical review. Hepatology 1993 Mar; 19: 518-33.
Plevak-DJ et al: Nutritional support for liver transplantation: identifying caloric and protein requirements [see comments]. Mayo-Clin-Proc. 1994 Mar; 69(3): 225-30.
Porter C & Cohen NH: Indirect calorimetry in critically ill patients: role of the clinical dietitian in interpreting results. J Am Diet Assoc, 1996 Jan, 96:1, 49-57.
Riggio, O. et al: Zinc Supplementation Reduces Blood Ammonia and Increases Liver Ornithine Transcarbamylase Activity in Experimental Cirrhosis. Hepatology, 1992;16(3):785-789.
Roe, D. Drug Induced Nutritional Deficiencies. Westport, Conn.: Avi Publishers, 1979.
Sherlock-S.: Alcoholic liver disease.. Lancet. 1995 Jan 28; 345(8944): 227-9.
Skullman-S et al: Protein synthesis in regenerating rat liver during malnutrition. J-Hepatol. 1994 Aug; 21(2): 174-81.
Tessari P et al., Response of phenylalanine and leucine kinetics to branched chain-enriched amino acids and insulin in patients with cirrhosis [see comments]. Gastroenterology, 1996 Jul, 111:1, 127-37.
Verboeket-van de Venne WP et al., Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: effects of the pattern of food intake. Gut, 1995 Jan, 36:1, 110-6.
Watanabe A et al., Tentative diet for liver failure containing well-polished rice. Nutrition, 1995 Jul-Aug, 11:4, 355-9.
Weber, F. L., Jr., et al: Effects of Branch Chain Amino Acids on Nitrogen Metabolism in Patients With Cirrhosis. Hepatology, June 1990;11(6):942-950.
Wyngaarden, J.B. & L.H. Smith. 1985. Cecil's Textbook of Medicine. Saunders Pub Co., Philadelphia. 2341 pp.
Zhao, M.Q., Han, D.W, MA, X.H., Zhao, Y.C., Yin, L., 1,1, C.M. Preventive and therapeutic effects of glycyrrhizin, glycyrrhetic acid and saikosides on experimental cirrhosis in rats. Acta Pbarm Sin 18 (1983): 325-33 1.
- Product Categories
- Detox & Immunity
- Digestive Health
- Joint Health
- Weight Loss
- Popular Products
- CellRenew Collagen Hyaluronic Acid
- Foundation Blue-Green Algae
- Dream Health System
- Liver Cleanse
- Reference Materials
- Product Testimonials
- Health Journal Archive
- Health Briefs
- Health Basics
- Frequent Product Q&A's
- Med-Scope (health database)
- Health Conditions
- Natural Solutions
- Alternative Therapies
- Toxicity Sources
- Foods Advice
- Anatomy & Fitness
We test only on humans